CLIA lab

CLIA 20D2329937: Belfast Drug Company

Belfast, ME. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 20D2329937 belongs to Belfast Drug Company in Belfast, ME.

Certificate of Waiver, effective September 9, 2025, expires September 8, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
September 9, 2025
Certificate expiration
September 8, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
September 9, 2025
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
20D2329937
Lab name
Belfast Drug Company
Address
15 Starrett Drive Unit G, Belfast, ME 04915
Phone
(207) 338-0441
Fax
(207) 338-3734

Annual test volume the lab reported

Waived tests
25

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Belfast, ME

Related

Questions

What is the CLIA number for Belfast Drug Company in Belfast?

20D2329937, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Belfast Drug Company hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 20D2329937 expire?

The CMS file lists September 8, 2027 as the certificate expiration date; the certificate took effect September 9, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.